The Centers for Medicare & Medicaid Services has finalized an indefinite delay in the start date of its radiation oncology model, according to a final rule published yesterday. AHA had urged CMS to delay the model’s launch, which was scheduled for January 2023, writing that the agency’s stated goal of using the model to ensure fair, predictable payment for radiation oncologists “has been marred by the incorporation of significant payment cuts and substantial administrative burdens for those participating in this mandatory model.” CMS will set a new start date through future rulemaking.

Related News Articles

Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…
Headline
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state’s 340B contract pharmacy law…